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Atherosclerosis is linked with both inﬂammatory and calciﬁc pro-
cesses occurring at the vessel wall. Novel imaging techniques (PET
CT analysis) have been developed to assess such processes using
18F-sodium ﬂuoride (18F-NaF e calciﬁcation) and 18F-ﬂuo-
rodeoxyglucose (18F-FDG e inﬂammation). Such imaging has been
predominantly undertaken within the coronary and carotid circu-
lation. This study is the ﬁrst to prospectively validate PET CT
analysis in peripheral arterial disease (PAD).
8 patients (16 legs; 5 men, median age 74.5 years) with inter-
mittent claudication underwent PET CT analysis using the 18F-NaF
and 18F-FDG tracers using standard protocols. For each scan, the
lower limb arterial tree was examined from the aortic bifurcation
to the ankle. The degree of arterial calciﬁcation (AC) was measured
using the modiﬁed Agatston score. Atherosclerotic disease burden
was analysed using Bollinger scoring method.
Overall whole limb median (IQR) TBR levels for 18F NaF was
1.30 (0.98e1.74) and for 18F FDG was 1.42 (1.11e1.75). The
median limb AC score was 1954.5 (1198e2216). Signiﬁcant cor-
relations were seen between FDG uptake and both NaF uptake and
AC and there was an inverse relationship between NaF tracer
uptake and AC (all p < 0.05). Increasing burden of atherosclerosis
was associated with lower NaF uptake and a higher AC (p < 0.05).
This study is the ﬁrst to validate PET CT analysis in patients with
PAD. It also starts to assess potential relationships between
inﬂammation and calciﬁcation. Further studies are required to look
at longer-term consequence of such ﬁndings with regard to
atherosclerotic progression/development.
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1078-5884/$ e see front matterInfra-popliteal bypass is an established and effective method for
limb salvage in patients with critical limb ischaemia (CLI). Sec-
ondary interventions maybe required in order to maintain graft
patency. The aim of this study was to look at the frequency and
outcomes of such interventions.
Consecutive patients undergoing bypasses onto the infra-
popliteal vessels for CLI (Rutherford 4-6) at a single institution
were analysed between 2009e2013. The primary end points were
graft patency, limb salvage and amputation-free survival at 12
months by Kaplan-Meier analysis.
A total of 122 infra-popliteal bypasses were performed in 108
patients. Distal anastomosis was on to the Anterior Tibial (n ¼ 37),
Posterior Tibial (n ¼ 28), Peroneal (n ¼ 24), Tibio-Peroneal Trunk
(n ¼ 24) or Dorsalis Pedis artery (n ¼ 9). Primary-patency, assisted
primary-patency and secondary-patency was 67%, 73% and 81%
respectively at 12 months and 58%, 68% and 78% respectively at
24 months. Amputation free survival was 79% at 12 months and
73% at 24 months. There were 101 endovascular and 14 open
secondary interventions performed on 61 (50%) threatened grafts.
Endovascular interventions included angioplasty of inﬂow/prox-
imal anastomosis (28%), outﬂow/distal anastomosis (39%), graft
stenosis (17%) and thrombolysis (17%). Amputation-free survival
was signiﬁcantly better in salvaged threatened grafts compared to
non-threatened grafts (Log rank test, P ¼ 0.043) and in grafts
requiring re-intervention later (>6 months from bypass) compared
to those requiring early re-intervention (<6 months, P ¼ 0.047).
Secondary interventions in threatened distal bypass grafts are
successful at maintaining graft patency. Careful duplex surveillance
of these complex bypasses and timely intervention is associated
with improved amputation free survival.
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Exercise is effective in improving walking distances and quality of
life (QoL) in patients with intermittent claudication. The aim of this
RCT was to determine whether the use of a wearable activity
tracker (Nike FuelBand; NFB) was more effective than standard
conservative therapy alone.
Thirty-seven claudicants were randomly allocated to either the
NFB (n ¼ 20) or control group (n ¼ 17). Three patients withdrew
from the study and seven (2 NFB, 8 control) were unable to attend
follow-up. Claudication distance (CD), maximum walking distance
(MWD), patient reported walking distance (PRWD) and QoL (Vas-
cuQol questionnaire) were measured at 0 (baseline) and 3-months.
Groups were well matched for age, sex, smoking status and
supervised exercise programme enrolment (NFB 11% vs control
33.3%, p ¼ 0.19).
At 3-months patients in the NFB group made signiﬁcant im-
provements in median (IQR) CD (45 (25.3e61.5) vs 54 (40.8e87.5)
e16 Abstractsm, p ¼ 0.017), MWD (80 (50e118.5) vs 111.5 (91.3e210.3) m,
p ¼ 0.013) and PRWD (201.5 (100e295) vs 382.5 (187.3e550) m,
p < 0.001). VascuQol score was also signiﬁcantly improved: 4.7
(3.8e5.3) vs 5.4 (5.2e5.7), p < 0.001. Patients in the control group
did not demonstrate any signiﬁcant differences in CD (28 (11e41)
vs 26 (24e49) m, p ¼ 0.26), MWD (53.5 (43e70) vs 69 (50e91) m,
p ¼ 0.107), PRWD (120 (55e220) vs 102.5 (55e250) m, p ¼ 0.50)
or VascuQol score (2.8 (2.8e5.0) vs 3.2 (2.4e5.2), p ¼ 0.64).
At 3-months signiﬁcantly higher improvements were seen in the
NFB group, as compared to the control group, for VascuQol score
(0.8 (0.4e1) vs 0.04 (0.3e0.3), p ¼ 0.004) and PRWD (143.5
(51.3e309) vs 0 (0e5) m, p ¼ 0.015), but not for MWD (15.5
(3e58.3) vs 20 (5e48), p ¼ 0.78) or CD (11.5 (1e22.3) vs 8
(5e10) m, p ¼ 0.32).
At 3-months the use of wearable activity tracker technology
improved PRWD and QoL to a greater extent than standard con-
servative therapy and may be used to encourage exercise habits.
NCT01822457 (http://www.clinicaltrials.gov)
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NICE guidance recommends consideration of CDT for proximal
DVT, with the aim of preventing post-thrombotic syndrome. This
study aimed to review practice in CDT for DVT across the North
West of England.
Retrospective case note review of all CDT for DVT between
March 2012eApril 2014. The following data was collected from
four vascular units covering a population of 2.9 million: patient
demographics, risk factors, site, interval from presentation to
intervention, intervention, complications and follow up.
Of 2560 cases of DVT identiﬁed, only 15 cases underwent CDT
(0.58%). Patients were mostly females (11F:4M) with median age 43
years (16e64). Twelve patients underwent catheter thrombolysis and
3 mechanical thrombectomy. Median treatment duration was 36
hours (range 1e9 6). IVC ﬁlter was deployed in 6 patients and veno-
plasty/stenting performed in six. Complete lysis was achieved in 13
patients. There were two bleeding complications; one minor, one
major (managed conservatively).NopatientshadPE.Median inpatient
stay was 7 days (range 5e23) and follow up range was 6e24 months.
CDTwas safe and effective though the number treated was lower
than would be expected and signiﬁcant variation in practice was
noted between units. Vigilance should be heightening amongst
admitting physicians to ensure that patients who would beneﬁt
from CDT are referred acutely to their regional vascular unit.
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It has been postulated that direct revascularisation (DR) of tribu-
tary vessels supplying a foot ulcer may have superior outcome in
terms of wound healing and amputation when compared toindirect revascularisation (IR). This study aims to clarify this hy-
pothesis in diabetic patients with Rutherford 5/6 skin changes.
A six year retrospective single-centre analysis of diabetic patients
with Rutherford 5/6 distal lower limb skin changes undergoing an
associated angioplasty was undertaken. All interventions were
performed using a standardised technique. Healing, amputation
and mortality data was recorded over 36 months. A provisional
analysis was performed of 60 patients, then formalised in 72.
72 patients were included. No differences were identiﬁed be-
tweenDR and IR in groups formedian time to healing (152.0 days and
144.0 days respectively) (p¼ NS), mortality (p¼ NS) or amputation.
This study adds to the few published studies which assess
outcomes by targeted revascularisation in diabetic patients. The
authors recommend maximising blood ﬂow through both direct
and indirect revascularisation.
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Meta-analysis has shown direct (the artery leading directly to the
tissue loss) angiosomal reperfusion to be superior to indirect reper-
fusion. Someunits perform combined (direct and indirect i.e. open up
as many tibial vessels as possible) reperfusion of the tibial vessels.
There was inadequate data published on combined tibial angioplasty
to performmeta-analysis in 2014. Our unit performs combined infra-
popliteal angioplasty routinely, where possible, so the aim was to
assess any advantage over traditional direct or indirect tibial angio-
plasty and to examine the effect of diabetes on the angiosomemodel.
Analysis of consecutive infra-popliteal angioplasties over a 5-
year period. Kaplan Meier survival curves were used to examine
differences between groups; p-values were corrected. Combined
angioplasty was performed routinely wherever possible.
Two hundred and sixteen tibial angioplasties were performed.
24.5% underwent combined revascularisation, 52.3% direct and
23.1% indirect. There was a signiﬁcant improvement in amputation
free survival (Hazard Ratio HR ¼ 1.652, p ¼ 0.019) in the direct
and combined groups over indirect revascularisation. However,
there was no improvement in wound healing (HR ¼ 1.163,
p ¼ 0.117). The direct vs combined comparisons showed no dif-
ference for any outcome (wound healing HR ¼ 0.947, p ¼ 0.849
and amputation HR ¼ 0.971, p ¼ 0.906). All trends were lost in
diabetic patients alone (n ¼ 149, 69% of group).
In this the largest series of combined angioplasty in the litera-
ture there was no advantage in opening up all the tibial vessels
with angioplasty if the angiosome directly supplying the ischaemic
tissue could be opened. The angiosome model does not appear
valid, however, in diabetic patients.
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The chimney technique offers an alternative to fenestrated/
branched endovascular solutions for juxtarenal and suprarenal
